Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Phase NA Recruiting
15 enrolled
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Phase NA Recruiting
80 enrolled
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
Recruiting
750 enrolled
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
Phase 2 Recruiting
46 enrolled
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
Phase 2 Recruiting
120 enrolled
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Phase 2 Recruiting
60 enrolled
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Phase 1 Recruiting
50 enrolled
BELIEVE
Recruiting
500 enrolled
The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy
Phase NA Recruiting
30 enrolled
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
Phase 1/2 Recruiting
31 enrolled
LUBRECA
Phase NA Recruiting
140 enrolled
PREACT
Phase NA Recruiting
66 enrolled
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Recruiting
1,200 enrolled
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
Phase 1 Recruiting
300 enrolled
DEBRA
Phase 3 Recruiting
1,670 enrolled
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
Phase NA Recruiting
300 enrolled
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Phase 1 Recruiting
36 enrolled
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
Recruiting
10 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
JS207 Combination Therapy in Triple-negative Breast Cancer
Phase 2 Recruiting
80 enrolled
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
Phase 2 Recruiting
768 enrolled
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
Recruiting
50 enrolled
ALLIANCE
Phase NA Recruiting
174 enrolled
Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC
Phase NA Recruiting
33 enrolled
PROSPER
Recruiting
200 enrolled
PREHAB-BC65
Phase NA Recruiting
90 enrolled
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Recruiting
480 enrolled
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
Phase 2 Recruiting
50 enrolled
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Phase 3 Recruiting
446 enrolled
AIMSS-RPS
Phase 2 Recruiting
20 enrolled
PRETORIA
Phase NA Recruiting
250 enrolled
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Phase 2 Recruiting
40 enrolled
Oral Aromatase Inhibitors Modify the Gut Microbiome
Recruiting
25 enrolled
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Phase 1/2 Recruiting
42 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
Phase 3 Recruiting
910 enrolled
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Phase 2 Recruiting
81 enrolled
FIBROTHERME
Phase NA Recruiting
110 enrolled
Biomarkers to Detect Endocrine Therapy Resistance
Phase 2 Recruiting
8 enrolled
PREDICT-RD
Phase 2 Recruiting
78 enrolled
Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer
Phase 1/2 Recruiting
86 enrolled
EVOLVE-BDT
Phase 2 Recruiting
700 enrolled
SPRING
Phase NA Recruiting
4,800 enrolled
SHERLOCK
Recruiting
7,000 enrolled
An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy
Phase NA Recruiting
40 enrolled
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
Phase NA Recruiting
100 enrolled
PALAVY
Phase 2 Recruiting
96 enrolled
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Recruiting
20 enrolled
CBD for Breast Cancer Primary Tumors
Phase 1 Recruiting
84 enrolled
TDXdose
Phase 4 Recruiting
210 enrolled